The work was led by Lysander Grospeaud, Romain Sonneville, and Etienne de Montmollin of AP-HP’s Hôpital Bichat-Claude Bernard in Paris, together with the EURECA Investigator Study Group, a broad network of intensive care clinicians spanning Europe and beyond. The parent EURECA cohort, funded by the European Society of Intensive Care Medicine, prospectively enrolled adult patients with meningoencephalitis requiring intensive care across multiple international centres, and an earlier publication in 2023 described the clinical features, etiologies, and outcomes of that population. The new scientific letter builds on that foundation by focusing specifically on the causes of death among patients who did not survive, and on the factors that pushed individual patients toward one mode of dying rather than the other.

This distinction matters because the two death pathways demand different clinical strategies. A death driven by neurologic causes, such as intractable intracranial hypertension, malignant brain edema, or refractory status epilepticus, invites aggressive neurocritical care: intracranial pressure monitoring in selected patients, osmotic therapy, seizure control, and early neuroimaging to detect surgical complications. A death driven by systemic causes, by contrast, reflects the failure of organs far from the central nervous system and calls for the full arsenal of general intensive care, from ventilatory and circulatory support to the prevention of ventilator-associated pneumonia, thromboembolism, and other intensive care complications. Knowing which patients are most likely to die through which route could, in principle, allow clinicians to target monitoring and preventive interventions more precisely.

The methodological strength of the EURECA approach lies in its prospective, multicenter design. Prospective enrolment means that data on presentation, etiology, treatment, and complications were collected according to a predefined protocol rather than reconstructed retrospectively from charts, reducing the information bias that plagues much of the literature on central nervous system infections. Multicenter recruitment across many countries guards against the idiosyncrasies of any single health system or referral pattern, producing a picture of severe meningoencephalitis that is more likely to generalise to intensive care units worldwide. The ancillary analysis reported in the new letter was conducted on anonymized data from the cohort and did not require additional ethical approval beyond the original authorisations, which were granted by the Comité de protection des personnes Sud Méditerranée 2, with national and local approvals at each participating site.

Severe meningoencephalitis remains one of the most feared presentations in critical care. Bacterial meningitis, most notably pneumococcal disease, has long been recognised as a devastating illness in adults, with landmark cohort studies from the Netherlands in 2004 and 2006 documenting high mortality and a heavy burden of intracranial complications such as cerebral herniation, cerebrovascular injury, and hearing loss. More recent work, including a 2024 retrospective multicenter cohort on severe pneumococcal meningitis, has reinforced how frequently these intracranial catastrophes occur even under modern care. Viral encephalitis, dominated by herpes simplex virus in adults, adds a different profile of injury, with seizures, limbic involvement, and prolonged encephalopathy, and a 2025 analysis in JAMA Network Open by members of the same French group examined long-term outcomes in critically ill adults with acute encephalitis. The EURECA programme sits squarely within this tradition, but its prospective international design gives it unusual weight.

By classifying deaths as neurologic or systemic, the new analysis reframes mortality in these infections not as a single undifferentiated outcome but as the endpoint of at least two distinguishable clinical trajectories. Patients on the neurologic trajectory are those in whom the brain injury itself proves fatal, whether through direct tissue destruction, mass effect and herniation, vascular complications, or uncontrollable electrical storm. Patients on the systemic trajectory die of the consequences of critical illness: refractory shock, respiratory failure, renal and hepatic dysfunction, and the cascade of organ support failures that define multi-organ dysfunction syndrome. The determinants of each trajectory are unlikely to be identical, and the study’s central contribution is to identify which baseline and early-course variables associate with each.

The clinical implications of such a stratification are considerable. If, for example, markers of severe brain injury at presentation, such as profound coma, seizures, or characteristic imaging findings, are found to predict neurologic death, then those patients might be candidates for earlier intracranial pressure monitoring, more aggressive neuroimaging, or transfer to centres with neurosurgical capability. Conversely, if systemic death is predicted by factors such as older age, pre-existing comorbidity, immunosuppression, or the causative organism, then those patients might benefit from intensified general critical care, earlier escalation of organ support, and vigilant prevention of intensive care unit complications. In both cases, the value of the analysis lies in converting a binary outcome, survival or death, into a more nuanced map of risk that can guide bedside decisions.

The study also speaks to a broader shift in how critical care research approaches central nervous system infections. For decades, outcome studies in this field reported mortality as a single figure, obscuring the fact that some patients die of their brain disease while others die of everything else. Distinguishing cause-specific death allows the field to ask sharper questions: Are intracranial complications becoming less lethal as neurocritical care improves? Is systemic mortality rising as patients survive longer on organ support? Are the two trajectories converging or diverging over time? Answering such questions requires the kind of granular, prospectively collected cause-of-death data that the EURECA investigators have now assembled, and it sets a template for future cohort studies in related conditions, from cerebral malaria to autoimmune encephalitis requiring intensive care.

There are, inevitably, limits to what any observational analysis can establish. Assigning a single cause of death in a critically ill patient is inherently judgment-dependent, and even with predefined criteria, the boundary between a neurologic and a systemic contribution can blur when brain-injured patients develop infections, thrombosis, and organ failure as downstream consequences of immobility and prolonged ventilation. The investigators addressed this by relying on the structured data collection of the parent cohort and by conducting the analysis on anonymized data under a predefined statistical plan, but cause-of-death classification remains an area where independent replication is valuable. The authors note that the data supporting the findings are available upon reasonable request, together with the study protocol and statistical analysis plan, which should facilitate scrutiny and reuse.

For clinicians, the practical message of the EURECA analysis is that death in severe meningitis and encephalitis is not monolithic, and that the fight against it must be waged on two fronts simultaneously. For researchers, the study demonstrates the power of large prospective international cohorts to resolve questions that single-centre series cannot touch. And for patients and families, it offers a sober but important form of transparency: an honest accounting of how these devastating infections kill, gathered from dozens of intensive care units and hundreds of clinical decisions, and published so that the next generation of care can be built on evidence rather than intuition. As the EURECA investigators continue to mine their cohort, the hope is that identifying the determinants of each death pathway will translate into fewer deaths on both of them.

Subject of Research: Causes of death and their determinants in critically ill adults with severe meningitis and encephalitis

Article Title: Determinants of neurologic causes and systemic causes of death in severe meningitis and encephalitis: insights from the international prospective multicenter EURECA study

Article References: Grospeaud, L., Sonneville, R., de Montmollin, E., on behalf of the EURECA Investigator Study Group, Aissaoui, N., Argaud, L., Audibert, J., Bailly, P., Balandín Moreno, B., Barbier, F., Ben Hadj Salem, O., Beuret, P., Boronat, P., Bourenne, J., Bruel, C., Bruneel, F., Calamai, I., Cariou, A., Chabanne, R., … Voiriot, G. (2026). Determinants of neurologic causes and systemic causes of death in severe meningitis and encephalitis: insights from the international prospective multicenter EURECA study. Intensive Care Medicine. https://doi.org/10.1007/s00134-026-08603-2

Image Credits: AI Generated

DOI: 10.1007/s00134-026-08603-2

Keywords: meningitis, encephalitis, intensive care, critical illness, neurologic death, systemic organ failure, EURECA study, central nervous system infection, sepsis, intracranial pressure, prognosis, multicenter cohort